Literature DB >> 31980481

ANGPTL3, PCSK9, and statin therapy drive remarkable reductions in hyperlipidemia and atherosclerosis in a mouse model.

Eva Hurt-Camejo1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31980481      PMCID： PMC7053832          DOI： 10.1194/jlr.C120000650

Source DB:  PubMed          Journal:  J Lipid Res        ISSN： 0022-2275            Impact factor:   5.922


× No keyword cloud information.
  13 in total

1.  Remnant Cholesterol and Triglyceride-Rich Lipoproteins in Atherosclerosis Progression and Cardiovascular Disease.

Authors:  Anette Varbo; Børge G Nordestgaard
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-11       Impact factor: 8.311

2.  Interleukin 6 stimulates endothelial binding and transport of high-density lipoprotein through induction of endothelial lipase.

Authors:  Jérôme Robert; Marc Lehner; Saša Frank; Damir Perisa; Arnold von Eckardstein; Lucia Rohrer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-10-10       Impact factor: 8.311

3.  Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review.

Authors:  Allan D Sniderman; George Thanassoulis; Tamara Glavinovic; Ann Marie Navar; Michael Pencina; Alberico Catapano; Brian A Ference
Journal:  JAMA Cardiol       Date:  2019-12-01       Impact factor: 14.676

Review 4.  Inflammasomes, neutrophil extracellular traps, and cholesterol.

Authors:  Alan R Tall; Marit Westerterp
Journal:  J Lipid Res       Date:  2019-02-19       Impact factor: 5.922

5.  Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.

Authors:  Gregory G Schwartz; P Gabriel Steg; Michael Szarek; Deepak L Bhatt; Vera A Bittner; Rafael Diaz; Jay M Edelberg; Shaun G Goodman; Corinne Hanotin; Robert A Harrington; J Wouter Jukema; Guillaume Lecorps; Kenneth W Mahaffey; Angèle Moryusef; Robert Pordy; Kirby Quintero; Matthew T Roe; William J Sasiela; Jean-François Tamby; Pierluigi Tricoci; Harvey D White; Andreas M Zeiher
Journal:  N Engl J Med       Date:  2018-11-07       Impact factor: 91.245

6.  PCSK9 deficiency reduces atherosclerosis, apolipoprotein B secretion, and endothelial dysfunction.

Authors:  Hua Sun; Ronald M Krauss; Jeffrey T Chang; Ba-Bie Teng
Journal:  J Lipid Res       Date:  2017-11-27       Impact factor: 5.922

7.  Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy Humans.

Authors:  Gissette Reyes-Soffer; Marianna Pavlyha; Colleen Ngai; Tiffany Thomas; Stephen Holleran; Rajasekhar Ramakrishnan; Wahida Karmally; Renu Nandakumar; Nelson Fontanez; Joseph Obunike; Santica M Marcovina; Alice H Lichtenstein; Nirupa R Matthan; James Matta; Magali Maroccia; Frederic Becue; Franck Poitiers; Brian Swanson; Lisa Cowan; William J Sasiela; Howard K Surks; Henry N Ginsberg
Journal:  Circulation       Date:  2016-12-16       Impact factor: 29.690

Review 8.  Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.

Authors:  Brian A Ference; Henry N Ginsberg; Ian Graham; Kausik K Ray; Chris J Packard; Eric Bruckert; Robert A Hegele; Ronald M Krauss; Frederick J Raal; Heribert Schunkert; Gerald F Watts; Jan Borén; Sergio Fazio; Jay D Horton; Luis Masana; Stephen J Nicholls; Børge G Nordestgaard; Bart van de Sluis; Marja-Riitta Taskinen; Lale Tokgözoglu; Ulf Landmesser; Ulrich Laufs; Olov Wiklund; Jane K Stock; M John Chapman; Alberico L Catapano
Journal:  Eur Heart J       Date:  2017-08-21       Impact factor: 29.983

9.  Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia.

Authors:  Zahid Ahmad; Poulabi Banerjee; Sara Hamon; Kuo-Chen Chan; Aurelie Bouzelmat; William J Sasiela; Robert Pordy; Scott Mellis; Hayes Dansky; Daniel A Gipe; Richard L Dunbar
Journal:  Circulation       Date:  2019-06-27       Impact factor: 29.690

10.  Alirocumab, evinacumab, and atorvastatin triple therapy regresses plaque lesions and improves lesion composition in mice.

Authors:  Marianne G Pouwer; Elsbet J Pieterman; Nicole Worms; Nanda Keijzer; J Wouter Jukema; Jesper Gromada; Viktoria Gusarova; Hans M G Princen
Journal:  J Lipid Res       Date:  2019-12-16       Impact factor: 5.922
View more
  3 in total

Review 1.  Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics.

Authors:  Yajun Duan; Ke Gong; Suowen Xu; Feng Zhang; Xianshe Meng; Jihong Han
Journal:  Signal Transduct Target Ther       Date:  2022-08-02

Review 2.  ANGPTL3 and Apolipoprotein C-III as Novel Lipid-Lowering Targets.

Authors:  Ioannis Akoumianakis; Evangelia Zvintzou; Kyriakos Kypreos; Theodosios D Filippatos
Journal:  Curr Atheroscler Rep       Date:  2021-03-10       Impact factor: 5.113

Review 3.  Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism.

Authors:  Tae Hyun Kim; Dong-Gyun Hong; Yoon Mee Yang
Journal:  Biomedicines       Date:  2021-12-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.